Company News
SPARC Receives ₹150 Cr Preferential Warrant Allotment Funds
Sun Pharma Advanced Research Company Ltd (SPARC) submits statutory auditor certificate confirming receipt of ₹149.99 crore for preferential warrant allotment.
Funds were received from Shanghvi Finance